Titre : Galectine -3

Galectine -3 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Refractive Errors
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Galectine -3 : Questions médicales les plus fréquentes", "headline": "Galectine -3 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Galectine -3 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-17", "dateModified": "2025-02-11", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Galectine -3" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Galectines", "url": "https://questionsmedicales.fr/mesh/D037161", "about": { "@type": "MedicalCondition", "name": "Galectines", "code": { "@type": "MedicalCode", "code": "D037161", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.503.307" } } }, "about": { "@type": "MedicalCondition", "name": "Galectine -3", "alternateName": "Galectin 3", "code": { "@type": "MedicalCode", "code": "D037502", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Çiğdem Yücel", "url": "https://questionsmedicales.fr/author/%C3%87i%C4%9Fdem%20Y%C3%BCcel", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry, University of Health Science, Ankara City Hospital, Ankara, Turkey." } }, { "@type": "Person", "name": "Aybeniz Civan Kahve", "url": "https://questionsmedicales.fr/author/Aybeniz%20Civan%20Kahve", "affiliation": { "@type": "Organization", "name": "Gazi University Faculty of Medicine, Department of Psychiatry, Ankara, Turkey." } }, { "@type": "Person", "name": "Işık Batuhan Çakmak", "url": "https://questionsmedicales.fr/author/I%C5%9F%C4%B1k%20Batuhan%20%C3%87akmak", "affiliation": { "@type": "Organization", "name": "Sungurlu State Hospital, Department of Psychiatry, Corum, Turkey." } }, { "@type": "Person", "name": "Erol Göka", "url": "https://questionsmedicales.fr/author/Erol%20G%C3%B6ka", "affiliation": { "@type": "Organization", "name": "University of Health Sciences, Ankara City Hospital, Department of Psychiatry, Ankara, Turkey." } }, { "@type": "Person", "name": "Massiullah Shafaq-Zadah", "url": "https://questionsmedicales.fr/author/Massiullah%20Shafaq-Zadah", "affiliation": { "@type": "Organization", "name": "Institut Curie, PSL Research University, U1143 INSERM, UMR3666 CNRS, Cellular and Chemical Biology Unit, 75248Paris Cedex 05, France." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Improving population-level refractive error monitoring via mixture distributions.", "datePublished": "2023-02-07", "url": "https://questionsmedicales.fr/article/36751103", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/opo.13105" } }, { "@type": "ScholarlyArticle", "name": "Factors contributing to long-term refractive error after cataract surgery.", "datePublished": "2023-01-02", "url": "https://questionsmedicales.fr/article/36592262", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10792-022-02630-w" } }, { "@type": "ScholarlyArticle", "name": "Deep learning for predicting refractive error from multiple photorefraction images.", "datePublished": "2022-08-08", "url": "https://questionsmedicales.fr/article/35941613", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12938-022-01025-3" } }, { "@type": "ScholarlyArticle", "name": "Utility for Uncorrected Refractive Errors in Adolescent Schoolchildren in Kakamega County, Kenya.", "datePublished": "2023-08-15", "url": "https://questionsmedicales.fr/article/37585852", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/OPX.0000000000002054" } }, { "@type": "ScholarlyArticle", "name": "High prevalence of refractive errors in an elderly population; a public health issue.", "datePublished": "2023-01-27", "url": "https://questionsmedicales.fr/article/36707798", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12886-023-02791-x" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Lectines", "item": "https://questionsmedicales.fr/mesh/D037102" }, { "@type": "ListItem", "position": 5, "name": "Galectines", "item": "https://questionsmedicales.fr/mesh/D037161" }, { "@type": "ListItem", "position": 6, "name": "Galectine -3", "item": "https://questionsmedicales.fr/mesh/D037502" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Galectine -3 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Galectine -3", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Galectine -3", "description": "Comment mesurer le taux de galectine-3 ?\nQuels tests sont utilisés pour le diagnostic ?\nLa galectine-3 est-elle un biomarqueur ?\nQuels médecins évaluent la galectine-3 ?\nPeut-on détecter la galectine-3 dans l'urine ?", "url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Refractive+Errors&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Galectine -3", "description": "Quels symptômes sont liés à la galectine-3 ?\nLa galectine-3 cause-t-elle des douleurs ?\nY a-t-il des symptômes cardiaques associés ?\nLa galectine-3 est-elle liée à la fatigue ?\nQuels signes cliniques sont observés ?", "url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Refractive+Errors&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Galectine -3", "description": "Comment prévenir l'augmentation de la galectine-3 ?\nL'exercice physique influence-t-il la galectine-3 ?\nY a-t-il des aliments à éviter ?\nLe stress affecte-t-il la galectine-3 ?\nDes suppléments peuvent-ils aider à la prévention ?", "url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Refractive+Errors&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Galectine -3", "description": "Quels traitements ciblent la galectine-3 ?\nLa galectine-3 peut-elle être traitée par des médicaments ?\nY a-t-il des traitements naturels pour la galectine-3 ?\nLes traitements varient-ils selon la maladie ?\nLa thérapie génique peut-elle cibler la galectine-3 ?", "url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Refractive+Errors&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Galectine -3", "description": "Quelles complications sont liées à la galectine-3 ?\nLa galectine-3 aggrave-t-elle les maladies ?\nY a-t-il des risques de cancer associés ?\nLa galectine-3 influence-t-elle la fibrose ?\nDes complications neurologiques sont-elles possibles ?", "url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Refractive+Errors&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Galectine -3", "description": "Quels facteurs augmentent la galectine-3 ?\nLe tabagisme influence-t-il la galectine-3 ?\nL'âge est-il un facteur de risque ?\nLe stress chronique est-il un facteur de risque ?\nY a-t-il un lien avec les maladies auto-immunes ?", "url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Refractive+Errors&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment mesurer le taux de galectine-3 ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le taux de galectine-3 se mesure par un test sanguin spécifique." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des examens d'imagerie peuvent être utilisés." } }, { "@type": "Question", "name": "La galectine-3 est-elle un biomarqueur ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est considérée comme un biomarqueur pour certaines maladies." } }, { "@type": "Question", "name": "Quels médecins évaluent la galectine-3 ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les cardiologues et oncologues évaluent souvent la galectine-3." } }, { "@type": "Question", "name": "Peut-on détecter la galectine-3 dans l'urine ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "La galectine-3 est principalement mesurée dans le sang, pas dans l'urine." } }, { "@type": "Question", "name": "Quels symptômes sont liés à la galectine-3 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Elle est associée à des symptômes d'inflammation et de fibrose." } }, { "@type": "Question", "name": "La galectine-3 cause-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut contribuer à des douleurs liées à des maladies inflammatoires." } }, { "@type": "Question", "name": "Y a-t-il des symptômes cardiaques associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme l'essoufflement peuvent être présents." } }, { "@type": "Question", "name": "La galectine-3 est-elle liée à la fatigue ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut être associée à la fatigue dans des conditions inflammatoires." } }, { "@type": "Question", "name": "Quels signes cliniques sont observés ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme l'œdème et la dyspnée peuvent être observés." } }, { "@type": "Question", "name": "Comment prévenir l'augmentation de la galectine-3 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant une alimentation équilibrée, peut aider." } }, { "@type": "Question", "name": "L'exercice physique influence-t-il la galectine-3 ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut réduire les niveaux de galectine-3." } }, { "@type": "Question", "name": "Y a-t-il des aliments à éviter ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les aliments transformés et riches en sucres peut être bénéfique." } }, { "@type": "Question", "name": "Le stress affecte-t-il la galectine-3 ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut augmenter les niveaux de galectine-3." } }, { "@type": "Question", "name": "Des suppléments peuvent-ils aider à la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certains suppléments, comme les oméga-3, peuvent être bénéfiques." } }, { "@type": "Question", "name": "Quels traitements ciblent la galectine-3 ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des inhibiteurs de galectine-3 sont en développement pour diverses maladies." } }, { "@type": "Question", "name": "La galectine-3 peut-elle être traitée par des médicaments ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments visent à réduire son activité dans le corps." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels pour la galectine-3 ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des approches diététiques et des suppléments peuvent aider à la réguler." } }, { "@type": "Question", "name": "Les traitements varient-ils selon la maladie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements dépendent de la maladie associée à la galectine-3." } }, { "@type": "Question", "name": "La thérapie génique peut-elle cibler la galectine-3 ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches explorent la thérapie génique pour moduler son expression." } }, { "@type": "Question", "name": "Quelles complications sont liées à la galectine-3 ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Elle est liée à des complications cardiovasculaires et pulmonaires." } }, { "@type": "Question", "name": "La galectine-3 aggrave-t-elle les maladies ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut aggraver des maladies comme l'insuffisance cardiaque." } }, { "@type": "Question", "name": "Y a-t-il des risques de cancer associés ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux élevés de galectine-3 sont associés à un risque accru de cancer." } }, { "@type": "Question", "name": "La galectine-3 influence-t-elle la fibrose ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle joue un rôle clé dans le développement de la fibrose tissulaire." } }, { "@type": "Question", "name": "Des complications neurologiques sont-elles possibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un lien entre galectine-3 et maladies neurodégénératives." } }, { "@type": "Question", "name": "Quels facteurs augmentent la galectine-3 ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'obésité, le diabète et l'inflammation chronique augmentent la galectine-3." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il la galectine-3 ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est un facteur de risque pour des niveaux élevés." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les niveaux de galectine-3 augmentent souvent avec l'âge." } }, { "@type": "Question", "name": "Le stress chronique est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut contribuer à des niveaux élevés de galectine-3." } }, { "@type": "Question", "name": "Y a-t-il un lien avec les maladies auto-immunes ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies auto-immunes peuvent augmenter les niveaux de galectine-3." } } ] } ] }

Sources (4326 au total)

Improving population-level refractive error monitoring via mixture distributions.

Sampling and describing the distribution of refractive error in populations is critical to understanding eye care needs, refractive differences between groups and factors affecting refractive developm... We used key informants to identify raw refractive error datasets and a systematic search strategy to identify published binned datasets of community-representative refractive error. Mixture models com... We obtained large raw refractive error datasets from the United States and Korea. The ability of our models to fit the data improved significantly from a single-Gaussian to a two-Gaussian-component ad... Mixture models appear able to describe the population distribution of refractive error accurately, offering significant advantages over commonly quoted simple summary statistics such as mean, standard...

Factors contributing to long-term refractive error after cataract surgery.

To evaluate factors that may influence the direction and extent of long-term refractive error after cataract surgery.... This was a retrospective observational study conducted across two private practices in Sydney, NSW, Australia. The study population consisted of patients who underwent cataract phacoemulsification sur... This study included 221 eyes of 122 patients. A refractive error within 1.00 D was achieved in 217 eyes (98.2%) at 3 years post-operatively. Mean prediction error decreased significantly between 2 mon... After cataract surgery, refractive outcomes may be influenced by ACD and ACD-to-AL ratio. The pre-operative assessment of these risk factors may better inform IOL selection in individual patients. Pro...

Deep learning for predicting refractive error from multiple photorefraction images.

Refractive error detection is a significant factor in preventing the development of myopia. To improve the efficiency and accuracy of refractive error detection, a refractive error detection network (... The results show that the mean absolute error (MAE) values of the spherical power, cylindrical power, and spherical equivalent can reach 0.1740 D (diopters), 0.0702 D, and 0.1835 D, respectively.... This method demonstrates a much higher accuracy than those of current state-of-the-art deep-learning methods. Moreover, it is effective and practical....

Utility for Uncorrected Refractive Errors in Adolescent Schoolchildren in Kakamega County, Kenya.

Uncorrected refractive errors (UREs) present an enormous lifetime burden in children. Despite this, there is a dearth of knowledge on URE-related preference-based quality of life (QoL) in East Africa.... This study investigated the preference-based QoL (utility) for URE in school-going adolescents of Kakamega County, in Kenya.... An observational cross-sectional study with multistage sampling was conducted on randomly selected secondary school adolescents. School-going adolescents in Forms 1 to 4 were clinically examined for t... A total of 330 participants aged 17.32 ± 1.60 years (URE, 17.50 ± 1.58 years; normal-sight, 17.15 ± 1.61 years) were included in the study. The mean utility score, as elicited by the Assessment of Qua... Uncorrected refractive errors are associated with reduced utility in school-going adolescents, regardless of URE subtype. Spectacle correction resulted in a significantly improved utility for those wi...

High prevalence of refractive errors in an elderly population; a public health issue.

To determine the prevalence of myopia and hyperopia and their associated demographic and ocular factors in people 60 years of age and above.... The sampling was performed using a multi-stage stratified random cluster sampling method. The complete demographic and case history information were collected through an interview. Then, all participa... Three thousand three hundred ten of 3791 invitees participated, and the data of 3263 individuals were analyzed for this report. The mean age of participants was 68.25 ± 6.53 (60 to 97) years, and 1895... The prevalence of refractive errors was high in the Iranian elderly population. A large percentage of the elderly still did not have complete visual acuity after the correction of refractive errors in...

Comparison of the new self-contained darkroom refractive screener versus table-top autorefractor and cycloplegia retinoscopy in detecting refractive error.

By comparing the results of the new self-contained darkroom refractive screener (YD-SX-A) versus table-top autorefractor and cycloplegic retinoscopy, to evaluate the performance of the YD-SX-A in dete... Cross-sectional study. 1000 participants between the ages of 6 and 18 who visited the Optometry Center of the People's Hospital of Guangxi Zhuang Autonomous Region from June to December 2022 were sele... The average age of participants was 10.77 ± 3.00 years, including 504 boys (50.4%) and 496 girls (49.6%). When YD-SX-A and cycloplegia retinoscopy (CR) were compared in the myopia group, there was no ... This study has identified that YD-SX-A has shown good performance in both agreement and effectiveness in detecting refractive error when compared with Topcon KR8800 and CR. YD-SX-A could be a useful t...

Corneal higher order aberrations by Sirius topography and their relation to different refractive errors.

To compare the root mean square (RMS) of anterior corneal higher-order aberrations (HOAs) in ametropic and emmetropic eyes.... This retrospective observational study was conducted at the Department of Ophthalmology, Tishreen University Hospital, Latakia, Syria. Study eyes were divided into four groups based on refractive erro... RMS values of total HOAs, trefoil and coma showed statistically significant differences in all four groups (P < 0.05, all). HOAs were noted to be lowest in the control group (0.18 ± 0.09, 011 ± 0.08 a... The mean RMS values of total HOAs, trefoil and coma were highest in the astigmatism group and lowest in the control group. However, spherical aberration was minimal in the astigmatism group. A better ...

Association analyses of rare variants identify two genes associated with refractive error.

Genetic variants identified through population-based genome-wide studies are generally of high frequency, exerting their action in the central part of the refractive error spectrum. However, the power... Genetic association analyses of non-cyclopaedic autorefraction calculated as mean spherical equivalent (SPHE) used whole-exome sequence genotypic information from 50,893 unrelated participants in the ... We found strong statistical evidence for association of SPHE with the SIX6 (p-value = 2.15 x 10-10, or Bonferroni-Corrected p = 4.41x10-06) and the CRX gene (p-value = 6.65 x 10-08, or Bonferroni-Corr... The results of our study support previous research highlighting the importance of rare variants to the genetic risk of refractive error. We explain some of the origins of the genetic signals seen in G...

Refractive errors and ocular findings in children and adolescents with mental disorders: a retrospective study.

An increasing prevalence of mental disorders (MDs) has been reported among children and adolescents. However, only few studies have conducted ocular examinations, including those on refractive status,... A total of 178 participants with MDs and 200 controls were recruited between April 2021 and May 2022. All the children and adolescents underwent cycloplegic or noncycloplegic autorefraction and retino... Twenty-seven percent of patients with MDs and 8% of controls had ocular findings, the most common of which were conjunctivitis, keratitis, and trichiasis. For refractive status, 70% (124/178) of patie... Ophthalmological examinations should be performed in children and adolescents with MDs because MDs are associated with a high prevalence of refractive errors and ocular diseases. Detection and interve...

Comparison of Three Different Devices for the Evaluation of Axial Length, Refractive Error, and Keratometry.

Myopia prevalence is increasing worldwide. Axial length, refractive error, and keratometry are important outcome measures in myopia management. Precise measurement methods are required for myopia mana... The aim of this study was to compare three different devices to evaluate axial length, refractive error, and keratometry.... A total of 120 subjects (37.7 ± 15.5 years) were enrolled in this prospective study. All subjects were measured with DNEye Scanner 2 (Rodenstock GmbH, Munich, Germany), Myopia Master (Oculus Optikgerä... Differences for axial length were as follows: DNEye Scanner 2 versus Myopia Master, 0.67 ± 0.46 mm; DNEye Scanner 2 versus IOLMaster 700, 0.64 ± 0.46 mm; and Myopia Master versus IOLMaster 700, -0.02 ... The results for axial length and keratometry from Myopia Master and IOLMaster were comparable. The axial length calculated by DNEye Scanner 2 was significantly different from interferometry devices an...